All matters presented for shareholder approval were overwhelmingly approved TORONTO, ON / ACCESS Newswire / June 25, 2025 / ...

AUSTIN, TX / ACCESS Newswire / June 25, 2025 / In 2025, your logo doesn’t represent the brand. Your face does. Consumers ...

VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / June 25, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTC ...

DENVER, CO / ACCESS Newswire / June 25, 2025 / ‘Who are you, anyway?’ is the question that opens bestselling author Niccole ...

Client-Focused Strategist Elevated to Lead Key Dealership Partnerships SCOTTSDALE, AZ / ACCESS Newswire / June 25, 2025 / ...

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Strategos Group is proud to announce the return of former Indiana ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held ...